/clinical/,/clinical/cckm-tools/,/clinical/cckm-tools/content/,/clinical/cckm-tools/content/beacon-protocols/,/clinical/cckm-tools/content/beacon-protocols/supportive-care/,

/clinical/cckm-tools/content/beacon-protocols/supportive-care/name-122960-en.cckm

201711331

page

100

UWHC,UWMF,

Tools,

Clinical Hub,UW Health Clinical Tool Search,UW Health Clinical Tool Search,Beacon Protocols,Supportive Care

CSC SC Pegfilgrastim (Neulasta) Every 3 Weeks Ver 11-20-17 (HL 1864)

CSC SC Pegfilgrastim (Neulasta) Every 3 Weeks Ver 11-20-17 (HL 1864) - Clinical Hub, UW Health Clinical Tool Search, UW Health Clinical Tool Search, Beacon Protocols, Supportive Care


CSC SC PEGFILGRASTIM (NEULASTA) EVERY 3 WEEKS VER: 11-20-17 –  Properties
Cycle 1 –  11/21/2017 through 12/11/2017 (21 days), Planned
Day 1, Cycle 1 –  Planned for 11/21/2017
Treatment Conditions
Treatment Condition A
Start date of supportive plan for pegfilgrastim should be appropriate based on start date of treatment plan (start
pegfilgrastim 1 day after chemo administered: generally 1-2 days after the start of the treatment plan).
Supportive Care Medications
pegfilgrastim (NEULASTA) soln prefilled syringe 6 mg
6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 2 –  12/12/2017 through 1/1/2018 (21 days), Planned
Day 1, Cycle 2 –  Planned for 12/12/2017
Treatment Conditions
Treatment Condition A
Start date of supportive plan for pegfilgrastim should be appropriate based on start date of treatment plan (start
pegfilgrastim 1 day after chemo administered: generally 1-2 days after the start of the treatment plan).
Supportive Care Medications
pegfilgrastim (NEULASTA) soln prefilled syringe 6 mg
6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 3 –  1/2/2018 through 1/22/2018 (21 days), Planned
Day 1, Cycle 3 –  Planned for 1/2/2018
Treatment Conditions
Treatment Condition A
Start date of supportive plan for pegfilgrastim should be appropriate based on start date of treatment plan (start
pegfilgrastim 1 day after chemo administered: generally 1-2 days after the start of the treatment plan).
Supportive Care Medications
pegfilgrastim (NEULASTA) soln prefilled syringe 6 mg
6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 4 –  1/23/2018 through 2/12/2018 (21 days), Planned
Day 1, Cycle 4 –  Planned for 1/23/2018
Treatment Conditions
Treatment Condition A
Start date of supportive plan for pegfilgrastim should be appropriate based on start date of treatment plan (start
pegfilgrastim 1 day after chemo administered: generally 1-2 days after the start of the treatment plan).
Supportive Care Medications
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Zztestonc,Fiona F [2462287]
11/21/2017 10:41:04 AM Page 1 of 2
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised: 11/2017CCKM@uwhealth.org

pegfilgrastim (NEULASTA) soln prefilled syringe 6 mg
6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 5 –  2/13/2018 through 3/5/2018 (21 days), Planned
Day 1, Cycle 5 –  Planned for 2/13/2018
Treatment Conditions
Treatment Condition A
Start date of supportive plan for pegfilgrastim should be appropriate based on start date of treatment plan (start
pegfilgrastim 1 day after chemo administered: generally 1-2 days after the start of the treatment plan).
Supportive Care Medications
pegfilgrastim (NEULASTA) soln prefilled syringe 6 mg
6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Cycle 6 –  3/6/2018 through 3/26/2018 (21 days), Planned
Day 1, Cycle 6 –  Planned for 3/6/2018
Treatment Conditions
Treatment Condition A
Start date of supportive plan for pegfilgrastim should be appropriate based on start date of treatment plan (start
pegfilgrastim 1 day after chemo administered: generally 1-2 days after the start of the treatment plan).
Supportive Care Medications
pegfilgrastim (NEULASTA) soln prefilled syringe 6 mg
6 mg, Subcutaneous, ONCE, 1 dose Starting when released
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Zztestonc,Fiona F [2462287]
11/21/2017 10:41:04 AM Page 2 of 2
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
11/2017CCKM@uwhealth.org